Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability?
Key facts
- Where
- Oslo, NorwaySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 45 and 80 years old?
Source: NCT06025448, who can take part
Where in Norway
- Lovisenberg Diaconal HospitalOslo, NorwayContact: Hanne Fuglø, MScTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Lovisenberg Diakonale Hospital
- Trial code
- NCT06025448
- Record updated
- 7 November 2023
- Original description
This clinical trial will investigate whether metallic lateralization in reverse shoulder arthroplasty is as stable as bony lateralization during the first two postsurgical years, measured with CT-based motion analysis (CTMA).Read full original descriptionShow less
From Cuff Arthropathy to Reverse Shoulder Arthroplasty - a Multicentre Randomized Control Trial (CARS 2: Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability Measured With CT-based Motion Analysis (CTMA)?).
This clinical trial will investigate whether metallic lateralization in reverse shoulder arthroplasty is as stable as bony lateralization during the first two postsurgical years, measured with CT-based motion analysis (CTMA).
Inclusion: Eligible for primary RSA due to OA, massive RC tear, failed RC repair or post-instability osteoarthritis; massive glenoid medialization; Able to read or write Norwegian.
Exclusion: Revision surgery; Dementia; Suspected chronic infection; Severe osteoporosis; Osteonecrosis of the humeral head; Poor deltoid function; ASA IV; Acute fracture.